Agilent Announces New SureSelect Human All Exon V8

Design provides comprehensive content and flexible exome options SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture exons that [...]

Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications

Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials MARLBOROUGH, Mass. -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the launch of Advanced Biopharma Solutions (ABS) as a premium service for biopharmaceutical companies interested in adopting multiplex immunofluorescence [...]

Cytiva acquires GoSilico to strengthen digital capabilities in bioprocessing

GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation More than 80% of mechanistic modelling users surveyed by Cytiva identified this as the future process development of chromatography Compared to traditional development approaches, mechanistic modelling saves significant time and materials on process development, since physical experiments [...]

Notice Regarding the Signing of Basic Agreement of Business Partnership between SHIMADZU and SHIONOGI for Wastewater Surveillance for Viruses in the Field of Infectious Diseases, Including Novel Coronavirus

Shimadzu Corporation (hearafter “Shimadzu”) and Shionogi & Co., Ltd. (hereafter “Shionogi”) announced that we have concluded the basic agreement of business partnership to target an early social implementation of wastewater surveillance for viruses in the field of infectious diseases, including the novel coronavirus (SARS-CoV-2). Shimadzu and Shionogi will progress to discuss of establishing a consortium [...]

Resolve Biosciences Launches Commercial Molecular Cartography™ Services to Provide Scientists with Highest-Resolution View of Subcellular Gene Expression

Company expands global footprint with opening of US facility and appoints industry veteran Chris Barbazette to lead rapidly growing commercial organization MONHEIM AM RHEIN, Germany, and SAN JOSE, Calif. – Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular Cartography™ service offering to provide scientists with the highest-resolution view of subcellular gene expression. Through [...]

Obatala Sciences licenses technology from Harvard University to advance discovery in obesity, diabetes, and cancer

NEW ORLEANS and CAMBRIDGE, Mass. -- Obatala Sciences, a biotechnology company that manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro. Obatala and Harvard Office of Technology Development announced the agreement today. Obatala [...]

TetraScience Announces New Integration to Accelerate Life Sciences R&D

BOSTON, MA -- TetraScience, Inc. announces a strategic partnership with Thermo Fisher Scientific to integrate the Thermo Scientific Momentum Workflow Scheduling Software with the Tetra Data Platform. The centralized platform allows scientists to automatically collect, centralize, and harmonize life sciences R&D data in the cloud to accelerate drug discovery and research. This integration combines bidirectional instrument control and increased automation readiness provided [...]

Apton Biosystems Appoints John W. Hanna as Chief Executive Officer and Board Director

PLEASANTON, Calif. -- Apton Biosystems, Inc., a developer of Super-Res™ sequencing instruments for large-scale clinical applications such as early cancer detection and population sequencing, today announced the appointment of John W. Hanna as chief executive officer and board director. Mr. Hanna has more than 20 years of senior healthcare management experience, including ten years at genomic diagnostics company [...]

Yokogawa Corporation of America to Contribute Bioreactor Expertise to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Yokogawa will co-innovate with industry leaders to advance biopharmaceutical development and manufacturing. Houston, Texas -- Yokogawa Corporation of America announces that the company has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as an industry member. Yokogawa will contribute expertise in bioreactor process control and automation through interaction with universities, industry-leading researchers and [...]

Genomenon and Nostos Genomics Partner to Accelerate Rare Genetic Disease Diagnoses

Nostos Genomics Integrates Mastermind Genomic Search Engine into AION Variant Interpretation Platform Genomenon® announced a partnership with Nostos Genomics, which includes integration of the Mastermind® Genomic Search Engine into their cloud-based AION variant interpretation platform. This integration will allow users of AION to preview the number of published articles related to their search and easily link out to view the evidence [...]

Access IBO on Knowledge Center